Medicines
Urgent field safety notice
FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors that may provide incorrect low glucose readings.
(Source: Abbott)
Patient resources
Diabetes technology
Online resource hub to help patients understand different diabetes technologies, what they can access and more.
(Source: Diabetes UK)
Learning and events
CPD module: Lipid management
Free 4-part series: lipids and triglycerides; risk assessment; statins; and other lipid-lowering therapies.
(Source: Primary Care Diabetes and Obesity Society)
CPD module: Obesity
Free 4-part series: starting the conversation about weight; assessment; lifestyle and behavioural changes; and pharmacological and surgical management.
(Source: Primary Care Diabetes and Obesity Society)
Peripheral artery disease and diabetes
Free interactive case study: the causes, diagnosis and management of PAD.
(Source: Diabetes & Primary Care)
Diabetes UK Professional Conference 2026
Register your interest in next year’s conference in Liverpool (22–24 April).
(Source: Diabetes UK)
Kidney health
Bite-sized mini-module on this diabetes-related complication.
(Source: Diabetes UK)
Diabetes and pancreatic cancer
Six-part introduction to diabetes and pancreatic cancer, and in-depth information on its management.
(Source: Pancreatic Cancer UK)
Guidelines, reports and position statements
DVLA modernises diabetes rules for bus and lorry drivers
Professional (Group 2) drivers with type 2 diabetes may now use technology to monitor their glucose levels. Plus leaflet for drivers.
(Source: Driver and Vehicle Licensing Agency)
ADA Standards of Care in Diabetes – 2026
Latest clinical practice recommendations of the American Diabetes Association, providing the components of diabetes care, general treatment goals and tools to evaluate quality of care.
(Source: Diabetes Care)
Supporting Women with Obesity Across the Reproductive Life
EASO position statement aiming to guide the health and medical assessment of women with obesity during their reproductive life.
(Source: European Association for the Study of Obesity)
Delivering diabetes care in a neighbourhood health service
Plan to provide more preventative care via a neighbourhood health service and the key steps to achieving it.
(Source: Diabetes UK)
Clinical assessment and acceptance criteria for CGM system performance
A proposed guideline by the IFCC Working Group on CGM.
(Source: Clinica Chimica Acta)
World Health Organization Guideline on the use and indications of GLP-1 therapies for the treatment of obesity in adults
WHO’s call to ensure that the opportunities offered by new therapies are universally accessible.
(Source: JAMA)
Joint position statement on the use of low- or no-calorie sweeteners (LNCS)
Produced by expert scientists representing the British Dietetic Association, British Nutrition Foundation and Diabetes UK.
(Source: BDA, BNF, DUK)
More Than Weight: Exploring the human, social and economic cost of obesity
Report outlining the cost of not acting on this public health challenge, and identifying failures and opportunities for change.
(Source: West Yorkshire Health and Care Partnership)
Continuous ketone monitoring for people with diabetes
International expert recommendations on the application of this new technology.
(Source: Lancet Diabetes & Endocrinology)
Funding opportunity
Call for applications 2026
Applications invited from healthcare professionals in the UK for research fellowship funding up to £300,000.
(Source: ABCD and NNUKRF)
Journals: Quick reads
Q&A: Type 2 diabetes remission
Professor Roy Taylor on the evidence base and how to support, assess and code remission. [Open access]
(Source: Diabetes & Primary Care)
Genetic risk-targeted islet autoantibody screening for presymptomatic type 1 diabetes in adults
Asymptomatic preclinical type 1 diabetes could be more likely in adults with elevated type 1 diabetes genetic risk score. [Open access]
(Source: Lancet Diabetes & Endocrinology)
Journals: Articles
Pharmacological therapies for type 2 diabetes: future approaches
Potential new non-insulin agents and pharmacological approaches in early development that aim to improve glycaemic control in type 2 diabetes. [Open access]
(Source: Diabetologia)
Synergistic associations of metformin and GLP-1 RA use with adiposity-related cancer incidence in people living with type 2 diabetes
Combination therapy yields “staggering” lowering of risk of all adiposity-related cancers. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity
Higher degree of weight regain associated with greater reversal of cardiometabolic benefits in SURMOUNT-4 analysis. [Open access]
(Source: JAMA Internal Medicine)
Insights into the mechanism of action of tirzepatide: A narrative review
Mechanistic activity of tirzepatide and its effect on glycaemic control, body weight, the cardiorenal system and lipid metabolism. [Open access]
(Source: Diabetes Therapy)
Global guideline recommended target achievements in glycaemic, blood pressure, and lipid control in type 2 diabetes
Little progress in achievement of risk factor targets globally revealed by meta-analysis. [Open access]
(Source: Diabetes Research and Clinical Practice)
Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes
Summary of the evidence, including assessment methods, factors relating to adherence and interventions. [Open access]
(Source: Diabetologia)
Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes
Systematic review and meta-analysis highlights potential cardiorenal benefits of combination therapy over monotherapy in a real-world setting. [Open access]
(Source: Diabetologia)
SGLT2 inhibitors in older adults with cardiovascular disease: A systematic review and meta-analysis
Robust evidence that SGLT2is confer substantial cardiovascular and survival benefits in this group. [Open access]
(Source: Journal of the American Geriatrics Society)
Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes
Restoration of normoglycaemia in people with prediabetes is associated with a reduced risk of type 2 diabetes subsequently. [Open access]
(Source: Diabetologia)
Assessing the independent and combined impact of obesity and gestational diabetes mellitus on adverse maternal outcomes
Combination of obesity and GDM amplifies risk for caesarean section and pre-eclampsia. [Open access]
(Source: Diabetic Medicine)
Exploring the social experiences, stigma and discrimination, faced by women with gestational diabetes
The experiences, impacts and perceived protective mechanisms of GDM-specific stigma among women in Australia.
[Open access]
(Source: Diabetic Medicine)
Continuous glucose monitoring frequency and glycemic control in people with type 2 diabetes
Frequent CGM use improves glycaemic control; clinicians should monitor at 6 months and identify any obstacles to its use. [Open access]
(Source: JAMA Network Open)
Thyroid, celiac, and other autoimmune diseases and the risk of incident type 1 diabetes in young adulthood
Autoimmune diseases in late adolescence associated with increased risk of type 1 diabetes in adulthood in both sexes. [Open access]
(Source: Diabetes Care)
Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019
Study identifies important targets for improvement through changes in health policy and care delivery. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors
Systematic analysis for the Global Burden of Disease Study 2023 underscores the growing impact of CKD. [Open access]
(Source: The Lancet)
Safety and tolerability of GLP-1 receptor agonists: A state-of-the-art narrative review
Comprehensive evaluation of the evidence, plus clinical strategies for adverse event mitigation and considerations for discontinuation or switching.
(Source: Drugs)
Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation
Prior GLP-1 RA use with discontinuation for pregnancy is associated with greater gestational weight gain.
(Source: JAMA)
SGLT2 inhibitors, GLP-1 receptor agonists, and frailty progression in older adults with type 2 diabetes
Frailty progression may be slowed through mechanisms independent of cardiovascular benefits.
(Source: Diabetes Care)
Young-onset hypertension confers higher risk of cardiovascular disease, kidney disease, and all-cause mortality in individuals with type 2 diabetes
Greater risks observed with young-onset hypertension compared with late-onset hypertension.
(Source: Diabetes Care)
Journal of
Diabetes Nursing
Issue:
Vol:29 | No:06
What’s hot in diabetes nursing? December 2025
Medicines
Urgent field safety notice
FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors that may provide incorrect low glucose readings.
(Source: Abbott)
Patient resources
Diabetes technology
Online resource hub to help patients understand different diabetes technologies, what they can access and more.
(Source: Diabetes UK)
Learning and events
CPD module: Lipid management
Free 4-part series: lipids and triglycerides; risk assessment; statins; and other lipid-lowering therapies.
(Source: Primary Care Diabetes and Obesity Society)
CPD module: Obesity
Free 4-part series: starting the conversation about weight; assessment; lifestyle and behavioural changes; and pharmacological and surgical management.
(Source: Primary Care Diabetes and Obesity Society)
Peripheral artery disease and diabetes
Free interactive case study: the causes, diagnosis and management of PAD.
(Source: Diabetes & Primary Care)
Diabetes UK Professional Conference 2026
Register your interest in next year’s conference in Liverpool (22–24 April).
(Source: Diabetes UK)
Kidney health
Bite-sized mini-module on this diabetes-related complication.
(Source: Diabetes UK)
Diabetes and pancreatic cancer
Six-part introduction to diabetes and pancreatic cancer, and in-depth information on its management.
(Source: Pancreatic Cancer UK)
Guidelines, reports and position statements
DVLA modernises diabetes rules for bus and lorry drivers
Professional (Group 2) drivers with type 2 diabetes may now use technology to monitor their glucose levels. Plus leaflet for drivers.
(Source: Driver and Vehicle Licensing Agency)
ADA Standards of Care in Diabetes – 2026
Latest clinical practice recommendations of the American Diabetes Association, providing the components of diabetes care, general treatment goals and tools to evaluate quality of care.
(Source: Diabetes Care)
Supporting Women with Obesity Across the Reproductive Life
EASO position statement aiming to guide the health and medical assessment of women with obesity during their reproductive life.
(Source: European Association for the Study of Obesity)
Delivering diabetes care in a neighbourhood health service
Plan to provide more preventative care via a neighbourhood health service and the key steps to achieving it.
(Source: Diabetes UK)
Clinical assessment and acceptance criteria for CGM system performance
A proposed guideline by the IFCC Working Group on CGM.
(Source: Clinica Chimica Acta)
World Health Organization Guideline on the use and indications of GLP-1 therapies for the treatment of obesity in adults
WHO’s call to ensure that the opportunities offered by new therapies are universally accessible.
(Source: JAMA)
Joint position statement on the use of low- or no-calorie sweeteners (LNCS)
Produced by expert scientists representing the British Dietetic Association, British Nutrition Foundation and Diabetes UK.
(Source: BDA, BNF, DUK)
More Than Weight: Exploring the human, social and economic cost of obesity
Report outlining the cost of not acting on this public health challenge, and identifying failures and opportunities for change.
(Source: West Yorkshire Health and Care Partnership)
Continuous ketone monitoring for people with diabetes
International expert recommendations on the application of this new technology.
(Source: Lancet Diabetes & Endocrinology)
Funding opportunity
Call for applications 2026
Applications invited from healthcare professionals in the UK for research fellowship funding up to £300,000.
(Source: ABCD and NNUKRF)
Journals: Quick reads
Q&A: Type 2 diabetes remission
Professor Roy Taylor on the evidence base and how to support, assess and code remission. [Open access]
(Source: Diabetes & Primary Care)
Genetic risk-targeted islet autoantibody screening for presymptomatic type 1 diabetes in adults
Asymptomatic preclinical type 1 diabetes could be more likely in adults with elevated type 1 diabetes genetic risk score. [Open access]
(Source: Lancet Diabetes & Endocrinology)
Journals: Articles
Pharmacological therapies for type 2 diabetes: future approaches
Potential new non-insulin agents and pharmacological approaches in early development that aim to improve glycaemic control in type 2 diabetes. [Open access]
(Source: Diabetologia)
Synergistic associations of metformin and GLP-1 RA use with adiposity-related cancer incidence in people living with type 2 diabetes
Combination therapy yields “staggering” lowering of risk of all adiposity-related cancers. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity
Higher degree of weight regain associated with greater reversal of cardiometabolic benefits in SURMOUNT-4 analysis. [Open access]
(Source: JAMA Internal Medicine)
Insights into the mechanism of action of tirzepatide: A narrative review
Mechanistic activity of tirzepatide and its effect on glycaemic control, body weight, the cardiorenal system and lipid metabolism. [Open access]
(Source: Diabetes Therapy)
Global guideline recommended target achievements in glycaemic, blood pressure, and lipid control in type 2 diabetes
Little progress in achievement of risk factor targets globally revealed by meta-analysis. [Open access]
(Source: Diabetes Research and Clinical Practice)
Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes
Summary of the evidence, including assessment methods, factors relating to adherence and interventions. [Open access]
(Source: Diabetologia)
Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes
Systematic review and meta-analysis highlights potential cardiorenal benefits of combination therapy over monotherapy in a real-world setting. [Open access]
(Source: Diabetologia)
SGLT2 inhibitors in older adults with cardiovascular disease: A systematic review and meta-analysis
Robust evidence that SGLT2is confer substantial cardiovascular and survival benefits in this group. [Open access]
(Source: Journal of the American Geriatrics Society)
Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes
Restoration of normoglycaemia in people with prediabetes is associated with a reduced risk of type 2 diabetes subsequently. [Open access]
(Source: Diabetologia)
Assessing the independent and combined impact of obesity and gestational diabetes mellitus on adverse maternal outcomes
Combination of obesity and GDM amplifies risk for caesarean section and pre-eclampsia. [Open access]
(Source: Diabetic Medicine)
Exploring the social experiences, stigma and discrimination, faced by women with gestational diabetes
The experiences, impacts and perceived protective mechanisms of GDM-specific stigma among women in Australia.
[Open access]
(Source: Diabetic Medicine)
Continuous glucose monitoring frequency and glycemic control in people with type 2 diabetes
Frequent CGM use improves glycaemic control; clinicians should monitor at 6 months and identify any obstacles to its use. [Open access]
(Source: JAMA Network Open)
Thyroid, celiac, and other autoimmune diseases and the risk of incident type 1 diabetes in young adulthood
Autoimmune diseases in late adolescence associated with increased risk of type 1 diabetes in adulthood in both sexes. [Open access]
(Source: Diabetes Care)
Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019
Study identifies important targets for improvement through changes in health policy and care delivery. [Open access]
(Source: Diabetes, Obesity and Metabolism)
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors
Systematic analysis for the Global Burden of Disease Study 2023 underscores the growing impact of CKD. [Open access]
(Source: The Lancet)
Safety and tolerability of GLP-1 receptor agonists: A state-of-the-art narrative review
Comprehensive evaluation of the evidence, plus clinical strategies for adverse event mitigation and considerations for discontinuation or switching.
(Source: Drugs)
Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation
Prior GLP-1 RA use with discontinuation for pregnancy is associated with greater gestational weight gain.
(Source: JAMA)
SGLT2 inhibitors, GLP-1 receptor agonists, and frailty progression in older adults with type 2 diabetes
Frailty progression may be slowed through mechanisms independent of cardiovascular benefits.
(Source: Diabetes Care)
Young-onset hypertension confers higher risk of cardiovascular disease, kidney disease, and all-cause mortality in individuals with type 2 diabetes
Greater risks observed with young-onset hypertension compared with late-onset hypertension.
(Source: Diabetes Care)
Latest news: Su steps down, continuous ketone monitoring, and why type 1 diabetes is aggressive in young children
Continuous ketone monitoring guidelines released
What’s hot in diabetes nursing? December 2025
Editorial: Passing the torch: looking back with pride, forward with hope
Su Down honoured with Lifetime Achievement Award
The impact of an integrated Primary Care Network Diabetes Clinical Nurse Specialist
Incorporating diabetes distress screening into diabetes specialist nurse clinics: views of DSNs
Developments that will impact your practice.
22 Dec 2025
Expert panel agrees on recommendations for the use of this novel technology.
18 Dec 2025
In her final editorial, Su Down reflects on her career and the remarkable progress in diabetes care she has seen.
11 Dec 2025
Journal of Diabetes Nursing’s Editor-in-Chief presented with award at the PCDOS National Conference.
4 Dec 2025